Related Experiment Video

Updated: Jun 26, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on: March 7, 2017

Inhibiting PI-3-K for glioma therapy

Garth Powis, Nathan T Ihle, W K Alfred Yung

    Cell Cycle (Georgetown, Tex.)
    |January 24, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jun 26, 2026

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
    08:46

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

    Published on: March 7, 2017

    Related Concept Videos

    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

    Articles linked to this work by shared authors, journal, and citation graph.

    Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiation.

    Nature genetics·2026

    Acquired genetic and cell-state changes in IDH-mutant glioma progression.

    Nature·2026

    Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.

    bioRxiv : the preprint server for biology·2025

    Oncogenic drivers shape the tumor microenvironment in human gliomas.

    bioRxiv : the preprint server for biology·2025

    The multilayered transcriptional architecture of glioblastoma ecosystems.

    Nature genetics·2025

    Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics.

    Nature genetics·2025

    Upregulation of ITM2A by p53 activation modulates p53 function through physical interaction.

    Cell cycle (Georgetown, Tex.)·2026

    The hormetic landscape: from evolutionary origination to mechanistic pathways in therapeutics.

    Cell cycle (Georgetown, Tex.)·2026

    The effect of energy metabolism on embryonic development and endometrial receptivity in patients with repeated implantation failure.

    Cell cycle (Georgetown, Tex.)·2026

    Integrated multi-level transcriptomic and bioinformatics analysis identifies lipid metabolism-ubiquitination signatures and reveals ATG5, ASB4, LDLR, and CD36 as Candidate biomarkers in insulin resistance.

    Cell cycle (Georgetown, Tex.)·2026

    The role of IL-37 in inflammatory bowel disease and colitis-associated colorectal cancer.

    Cell cycle (Georgetown, Tex.)·2026

    Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma.

    Cell cycle (Georgetown, Tex.)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us